tirzepatide nejm surmount-1 weight loss percent 2022 Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial Tirzepatide as Compared with Semaglutide

Study findings showed that oral semaglutide use was associated with significant improvements in blood sugar control, reduced body weight, improved several lipid markers, and reduced alanine aminotransferase (ALT), a liver enzyme marker, in study participants

Orforglipron is investigational

It doesnt matter if you are strong, weak

Mild symptoms: monitoring approach If you experience occasional right-sided discomfort after fatty meals that resolves within 30 minutes and does not involve fever or jaundice, this may represent biliary colic from small, asymptomatic stones

Meike Ying, Xue Shao, Hongli Qin, Pei Yin, Yushi Lin, Jie Wu, Jingjing Ren, Yang Zheng

While research shows modest exposure can improve guideline-recommended prescribing, extensive marketing enables companies to solidify branding power and maintain higher prices